Composition and methods for treating an aneurysm
US-2024390403-A1 · Nov 28, 2024 · US
Anti-cancer activity of (E)-1-(3′,4′-dimethoxyphenyl)butadiene
US9833422B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9833422-B2 |
| Application number | US-201615361053-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 24, 2016 |
| Priority date | Jan 7, 2016 |
| Publication date | Dec 5, 2017 |
| Grant date | Dec 5, 2017 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a method of using (E)-1-(3′, 4′-dimethoxyphenyl) butadiene to induce anti-tumorigenic effects in pancreatic carcinoma, ovarian carcinoma and prostate carcinoma. The invention also provides a method of using (E)-1-(3′, 4′-dimethoxyphenyl) butadiene to prevent cancer metastasis.
First claim
Opening claim text (preview).
We claim: 1. A method of inducing anti-tumorigenic effect on prostate carcinoma cells, ovarian carcinoma cells or pancreatic carcinoma cells, said method comprising step of treating said cells with effective amount of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene. 2. A method of inhibiting the progression and metastasis of pancreatic carcinoma cells, said method comprising step of treating said pancreatic carcinoma cells with effective amount of (E)-1-(3′,4′-Dimethoxyphenyl)butadiene to bring about the effect of significant reduction in cell adhesion molecule expression thereby inhibiting carcinoma progression and metastasis wherein cell adhesion molecule is selected from group consisting of P-selectin, E-selectin and L-selectin.
Assignees
Inventors
Classifications
Antineoplastic agents · CPC title
specific for metastasis · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for genital or sexual disorders (for disorders of sex hormones A61P5/24); Contraceptives · CPC title
of the prostate · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9833422B2 cover?
- The present invention provides a method of using (E)-1-(3′, 4′-dimethoxyphenyl) butadiene to induce anti-tumorigenic effects in pancreatic carcinoma, ovarian carcinoma and prostate carcinoma. The invention also provides a method of using (E)-1-(3′, 4′-dimethoxyphenyl) butadiene to prevent cancer metastasis.
- Who is the assignee on this patent?
- Majeed Muhammed, Nagabhushanam Kalyanam, Sami Labs Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K31/09. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Dec 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).